< Back to previous page
Researcher
Philippe Gevaert
- Keywords:allergy, chronic rhinosinusitis, allergic rhinitis
- Disciplines:Allergology, Rhinology, Applied immunology, Otorhinolaryngology not elsewhere classified
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → Today - Department of Otorhinolaryngology (Department)
Responsible
From1 Feb 2014 → 30 Sep 2018 - Department of Otorhinolaryngology (Department)
Member
From1 Feb 2014 → 30 Sep 2018 - Department of Otorhinolaryngology (Department)
Member
From1 Oct 1998 → 30 Sep 2018
Projects
1 - 10 of 12
- Local inflammation in Allergic Rhinitis and Chronic Rhinosinusitis with and without Nasal PolypsFrom1 Jan 2024 → TodayFunding: BOF - projects
- The who, where and when of airway immunoglobulins: dissecting the mechanisms leading to local modulation of allergic airway disease.From1 Nov 2022 → TodayFunding: FWO fellowships
- Understanding the division of labour between local and systemic humoral responses in allergic airway disease.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- An integrated approach to unravel eosinophil function in chronic eosinophilic disordersFrom1 Jan 2022 → TodayFunding: FWO EOS
- CHITINAIR: the role of CHItinases and chitinase like proteins in human Type 2 INflammatory AIRway diseasesFrom1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
- Protease dependent regulation of IL-33 activity in allergic airway inflammationFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Mode of action of house dust mite specific immunotherapy.From1 Jan 2014 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Food allergy after pediatric liver transplantation: role of the immature immune system and liver in oral toleranceFrom1 Jan 2014 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Mode of action of house dust mite specific immunotherapy.From1 Oct 2013 → 30 Sep 2017Funding: BOF - Other initiatives, FWO fellowships
- Diagnostic and therapeutic consequences of mucosal lymphoid accumulation and local IgE in the noseFrom1 Feb 2010 → 30 Sep 2015Funding: BOF - Doctoral projects
Publications
1 - 10 of 207
- Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2) : phase 3, randomised, double-blind, parallel trials(2025)Published in: LANCETISSN: 1474-547XIssue: 10482Volume: 405Pages: 911 - 926
- Endotyping in chronic rhinosinusitis : an EAACI Task Force report(2025)Published in: ALLERGYISSN: 1398-9995Issue: 1Volume: 80Pages: 132 - 147
- Expert consensus on surgical management of primary diffuse type 2‐dominant chronic rhinosinusitis(2025)Published in: INTERNATIONAL FORUM OF ALLERGY & RHINOLOGYISSN: 2042-6984Issue: 3Volume: 15Pages: 303 - 316
- Nonallergic rhinopathy : a comprehensive review of classification, diagnosis, and treatment(2024)Published in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEISSN: 2213-2201Issue: 6Volume: 12Pages: 1436 - 1447
- EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP(2024)Published in: RHINOLOGYISSN: 0300-0729Issue: 3Volume: 62Pages: 287 - 298
- Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP(2024)Published in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYISSN: 1097-6825Issue: 6Volume: 154Pages: 1442 - 1449
- Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up(2024)Published in: INTERNATIONAL FORUM OF ALLERGY & RHINOLOGYISSN: 2042-6984Issue: 1Volume: 14Pages: 18 - 31
- Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study(2024)Published in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEISSN: 2213-2201Issue: 7Volume: 12Pages: 1865 - 1876.e6
- Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial(2024)Published in: WORLD ALLERGY ORGANIZATION JOURNALISSN: 1939-4551Issue: 1Volume: 17
- Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa(2024)Published in: SCIENCE TRANSLATIONAL MEDICINEISSN: 1946-6242Issue: 770Volume: 16